SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " weight " 1,141 found 🔀 AI-powered Shuffle
Nintendo Shares Slide After 2026 Game Showcase Disappoints
Nintendo Co.’s shares fell by the most in a month after the game maker’s presentation of upcoming games came up short on brand-new titles from heavyweight franchises such as Mario.
Can California afford to cover Ozempic for public employees?
California may require CalPERS health plans to cover Ozempic and other GLP-1 weight-loss drugs. The insurer warns it would cost hundreds of millions of dollars.
Trouble Ahead For GLP-1 Drugs As Health Plans Stop Paying
Half of U.S. employers and health plans are balking at paying for GLP-1 drugs like Ozempic, Zepbound and Wegovy for weight loss and obesity treatment, a new report shows.
New CKM guideline urges early weight talks to prevent health risks
Talk about healthy weight now to prevent serious heart, kidney and metabolic problems later, new treatment guideline says. #CKMsyndrome
These teens have the weight of the world on their shoulders. Mental health is taking a nosedive
"Everyone is going through something," one California teen said about the prevalence of mental health concerns among his peers.
We can create the future of science right now
Paul Litvak is the founder and Executive Director of the Robyn Dawes Institute and a Visiting Scholar at UC Berkeley. He has a PhD in Behavioral Decision Research from Carnegie Mellon where he studied emotions and the sunk cost bias. Over 15 years in industry, he solved a wide range of challenging technical problems. At Meta he created models optimizing the ad review process. At Google he ran experiments to measure social influence. At Airbnb, he was a product manager leading machine learning teams optimizing search ranking and price suggestions. He also co-founded and led product at Rhythmic Health, a venture-backed biosensing startup, creating an accurate low cost system using a color changing strip and a smart phone to measure salivary lactate. The bottleneck At this point, it is uncontroversial to say that science needs to stop using the PDF article as the unit of knowledge and currency. The unbearable slowness of scientific publishing, the profit motive and margins: I’m not saying anything new. The PDF also sucks because it’s hard to extract structured information, which makes it hard to do evidence synthesis. As a result, we do much less evidence synthesis than is needed. And evidence synthesis ultimately undergirds most policy and medical decision-making. I can see second-by-second real-time odds for any sporting or newsworthy event, but a school board can’t see the best evidence on whether their 8th graders should be taught algebra. As a society, we don’t treat this as an important problem. Again, not controversial. Not only is the problem well understood, but the solution has already been laid out. What we need is AI-assisted living evidence synthesis - (1) an open knowledge graph of atomic claims, (2) claims linked to evidence, (3) assessment and synthesis of each piece of evidence, and (4) continuous updating with new data. What few realize (yet) is that the technical capacity to build this vision for a significant portion of science already exists. Not only that, scientists and startup teams are already building many of these components. I know this because I’ve been surveying the space and talking to many of the builders. There are some missing pieces: for example, evaluations of how well some of the components work. But at this point, most of what’s missing is a fully end-to-end working integration of all of these parts. In the rest of this essay, I’m going to lay out all the parts of a working living evidence layer for science and who is working on them, and propose concrete next steps for building this system. What’s now possible The diagram above outlines the components of a living evidence synthesis platform, including some of the teams working on each component1. Scientific PDFs are processed into claims with associated evidence. The evidence is subjected to a forensic audit, methodological evaluation and robustness and reproducibility checks. Finally it’s given a weight in a continuously updating synthesis. What follows is a description and status of each component and a few of the teams working on them. Document understanding The first thing you need to be able to do is turn an article into structured data. Mostly that means parsing PDFs. There are often multicolumn layouts that confuse non-specialized PDF to text processing libraries. For scientific papers, there is the added complexity of parsing formulas and tables and figures. This is a really hot area - there are startups offering APIs, and it seems like a new open source package gets posted to Github every few weeks. What follows isn’t exhaustive. A package called GROBID was the state of the art for a while, they didn’t update their package for nearly two years until very recently. In the meantime reducto.ai released an AI powered PDF extraction API, PaddleOCR became popular, IBM released a model called Docling, and both Mistral and Gemini created models and libraries. I also know of at least one other well-funded psychology research group working on a paper parser. By contrast, there are few open evals in this space, with no extensive evals for complex table comprehension in particular. Nonetheless, I’m confident this will be a solved problem soon, given the combination of LLM advances and developer interest. Hypothesis level extraction There has been increasing interest in comprehending the extracted text of papers and linking information to evidence for each hypothesis. A lot of work has already been done. Trialstreamer (Marshall et al. 2020) and RobotReviewer LIVE (Marshall et al. 2023) demonstrated automated extraction of trial population, intervention, and outcome at scale on clinical RCTs. PaperQA2 (Skarlinski et al. 2024) and Ai2 ScholarQA (2024) extended this to retrieval-augmented question answering with citation grounding. Elicit, Consensus, and SciSpace operationalized claim-level extraction for end users. OpenEval (Booeshaghi et al. 2026) is the most recent and most ambitious: 1.96 million atomic claims extracted from 16,087 eLife manuscripts using Claude Sonnet 4.5, grouped into ~299,000 results, with LLM evaluations showing 81% agreement with human peer review on a 2,487-paper subset. None of these solutions link claims to test-statistics, as you would need to evaluate randomized controlled trials. This is why I built the evidence.guide API - to extract hypotheses and associated test statistics from behavioral science papers. The best public eval of this kind of extraction I’m aware of comes from the recent SCORE project - they had humans code thousands of psychology papers to extract their claims by hand. It would be extremely helpful to the world if all scientific PDFs were available as structured open data. I’ve been working to make this happen, both directly at Berkeley and through coordination with large entities I can’t yet speak of; as hard as it is to do, I think it’s possible2. Forensic audit A lot of work has been done on forensic audit, but some gaps remain. Of course, for biology papers that rely on images for evidence, there are a variety of tools (notably Proofig and ImageTwin) to spot anomalies. These are still well short of what sleuths like Elizabeth Bik can do on her own, but these tools are constant companions among fraud analysts. There’s someone working on auditing Excel files for anomalies, and a number of teams are automating numerical checks like GRIM and SPRITE, including Scrutiny project, the INSPECT-SR team as well as statcheck. The regcheck team is building a way to use AI to compare preregistrations to analyses in papers, to ensure there aren’t significant deviations. Nonetheless, there are many other kinds of anomalies to screen for, both public and less publicly known. And there are no formal evals for anomaly detection that I’m aware of. Still, there’s a lot to draw from in this space and I’m pretty certain we will be able to scan papers for most kinds of obvious anomalies in the near future. Methodological review This area has been white hot, though I fear for many of the startups in this space, because this capability may become commoditized. There are at least six different AI peer review companies, including Refine.ink, Reviewer3, ReviewerZero.ai, Q.E.D. Science, Paper Wizard, and Isitcredible. Coarse (a pun on refine) was also recently created as an open source alternative. These systems provide qualitative feedback on the content of papers, spotting methodological weaknesses and mathematical errors. They seem to work pretty well, and many academics report bitterly that they exceed the average quality of typical peer reviewers. But there are few evals here either. What evals exist so far involve using LLM-as-judge (circularity problems abound) or comparing against human reviews of questionable quality. What you’d ideally want is an eval that measures capturing known errors in papers3. Reproducibility and robustness Another active area has been using AI agents to automate computational reproducibility4 and robustness5 checks in papers that report numerical results. For more recent papers where data and code are available, AI agents can see whether they can re-run the analyses and produce the numbers reported in the published paper. In addition to a handful of individual academics who have been experimenting using Claude Code for this, the Institute for Replication is a leading group working on building an end to end system. The evals related to this problem are the most mature, with CORE-Bench (Siegel, Kapoor, Narayanan 2024) and PaperBench (OpenAI 2025) available to benchmark agents on this task. There is also work on getting AI agents to test alternative ways of analyzing the data to ensure the results are robust to small analytic design choices. Synthesis This is the most underdeveloped area where significant investment is required. Although some automated evidence synthesis systems exist — for example, otto-sr is building an AI agent to write systematic reviews — none of these incorporate the full range of paper level signals to weight evidence appropriately. Nor is there anything like an eval or a gold standard for a good systematic review. Arguably Cochrane reviews are the closest we have to gold standard human systematic reviews, though I’ve heard academics in the know complain about their uneven quality. A key question for a synthesis platform is how to weight anomalies and methodological issues in assessing the quality of a piece of evidence. This is an unsolved problem and one I’m very keen to work on. Continuous updating There are many pieces of basic infrastructure available for monitoring for new research and initiating updates. OpenAlex is the current open citation graph. Retraction Watch integrated into Crossref in October 2023. Scite tracks how citations support, contrast, or mention prior claims. The Living Evidence Network demonstrated continuous-update workflows in clinical guidelines. Engineering this is a relatively straightforward task. When you look over this technical architecture and all the progress being made, it’s hard not to be optimistic that a living guide to scientific evidence will be built. The stakeholders are ready The social infrastructure for this is starting to coalesce — it’s not just a pie in the sky academic exercise to imagine this coming into existence. Institutions like the Center for Open Science, the Institute for Replication, the INSPECT-SR, the Living Evidence Network and more are all working on scaling work to improve research quality. Funders are also aligned. The Sloan Foundation has funded living evidence work through COS. Coefficient Giving supports the Institute for Replication and COS. The Astera Institute and the Institute for Progress have shown interest in this space. NIH has established an Office for Replication and Reproducibility. Although there are (very unfortunately) serious headwinds in science funding generally, there is an active group of funders interested in metascience. A brief word about what I’ve been doing at RDI. First, as a Visiting Scholar at Berkeley I’ve been actively figuring out how a non-profit and a public university can conduct and make public the results of large-scale academic article data mining. With some of the money I raised from donors, I commissioned a legal analysis of recent case law and publisher text data mining (TDM) agreements in order to understand whether a massive open data mining of academic articles is possible (with caveats, it is). I’ve also been working to bring together stakeholders in this space, and identify gaps. I’ve also been doing some software development in this space, with more to come. A pilot proposal The assumption undergirding all of this is that an AI, given all this information, would make the right judgment about a scientific claim with lots of conflicting evidence, weighing all the factors appropriately. That’s the hypothesis we need to test. Randomized control trial research is the best place to focus on first. RCTs are used to make many of the important decisions in society - from medical trials to public policy changes. And they use a relatively uniform set of inferential statistics with lots of known and available diagnostics. Behavioral science experiments, within the broader realm of RCTs, should be first used as a testbed whose results can be generalized. Because behavioral science is at the vanguard of open science practices, replications abound (there are thousands of them) to serve as ground truth training data. Key Hypothesis Therefore the pilot would test, in behavioral RCTs that have been replicated, whether the quality of evidence for a claim can be used to accurately predict whether that claim will replicate. Secondary Hypotheses Compared to claims that replicated, non-replicated claims demonstrate a greater share of forensic anomalies in their source literatures. Hypothesis level claim and statistic extraction is accurate enough to scale living evidence without onerous human review costs. Replication prediction is more accurate than prediction markets6 or journal prestige. If all the different quality signals we gather do accurately predict which studies will replicate, then we can use that model to score evidence to power the living evidence layer. Why this is informative regardless of outcome If the pilot succeeds, the architecture extends to medical RCTs (where Living Evidence already operates and integration is mostly about claim representation), then to slices of basic biology with stable replication structure. If it fails, the field learns which quality signals are load-bearing and which ones metascience has oversold. Either result is a contribution to knowing what the literature supports. Implications for funders Because this burgeoning ecosystem of builders already exists, a well-informed philanthropic or government funder could play a crucial catalyzing role in bringing this future about. They could play at least three roles: creating open structured datasets, publishing open benchmarks and incentivizing the solving of key technical challenges. First, open archives of papers that the government maintains, like PubMed, could be turned into structured data amenable to large scale metascience and claim aggregation. I know the US government already has an interest in doing this, though some key open questions remain unanswered. How do you determine the best models and systems for accurately extracting information from papers? How can you establish a robust way to allow researchers to flag errors and correct them? And finally, how do you create a legal regime in working with publishers to maximize the scope of available papers? For the latter, a university or a private philanthropy may be better positioned to make structured data publicly available under journal subscription terms or fair use. Philanthropists or government funders could also coordinate to create or commission benchmarks that evaluate whether important problems have been solved. For example, an open benchmark for claim extraction from a range of different scientific article types would be extremely helpful. Ensuring the underlying data are accurate is vital for creating these evaluations. I’ve discussed opportunistically using various human-created datasets for this purpose, but a consistent problem is that errors in human data make it difficult for them to serve as a gold standard. Finally, with structured data and benchmarks available, the government or private philanthropy could use them to incentivize groups to develop machine learning systems that meet these benchmarks. Prizes are one potentially valuable tool for this. For example, you could establish a prize for a system that accurately updates a living meta-analysis for a small set of claims. Prizes are particularly useful as signals of problem importance, and can help create vibrant ecosystems of public and private research—see, for example the role the government played in kickstarting the current work on nuclear fusion. Conclusion The drawbacks of the current scientific publishing system are known. Scientists agree, metascientists agree, philanthropists agree: the published PDF plus citation graph isn’t the right substrate for maintaining a representation of the evidence base in science. The pieces needed to build the alternative either already exist or are rapidly taking shape. The community is forming around exactly this problem, with concrete partnerships and shared infrastructure. A pilot should start on behavioral science RCTs because that’s the slice of empirical science most amenable to legibility, where replication ground truth is richest, and where the failure modes are best documented. What’s been missing is the galvanizing mission to assemble these pieces into something that works. That’s what I’m proposing to build. *** 1 I have a broader field map that I’ll release publicly soon. This is me, building in public! 2 If this is something that you are excited about, please reach out and talk to me. 3 More on this very soon too! 4 This tests whether, given the code and the data, you can get the same statistics as reported in the published paper. 5 This tests whether the results are the same as a paper’s given alternative analytical decisions in conducting the analysis (like outlier omission). Closely related is the idea of a “multiverse” where you come up with many different ways of answering the same underlying research question with the same data, and test whether the results hold in all those alternative methods. There’s been work on the latter as well. 6 Some of the replications, e.g. those from the SCORE project, had paired the experiments with forecasts from prediction markets. So we get to look at this for free.
Lighter X-ray aprons could spare health care workers from chronic pain
A light, flexible polymer material developed at the University of Waterloo could replace the lead in heavy X-ray aprons, providing the same protection from harmful radiation while reducing their weight ...
UFC Freedom 250 Countdown: Ilia Topuria vs. Justin Gaethje
UFC Freedom 250 marks another historic moment for the UFC when the Octagon touches down at the White House, where lightweight king Ilia Topuria faces interim champ Justin Gaethje. Plus, Alex Pereira and Ciryl Gane battle for interim heavyweight gold. UFC Freedom 250 Countdown previews the upcoming ...
Lighter X-ray aprons could spare health-care workers from chronic pain
Researchers at the University of Waterloo have developed a lightweight, flexible polymer material that could replace lead in X-ray aprons while providing comparable protection from harmful radiation. By incorporating specially engineered tungsten nanoparticles into a silicone-based nanocomposite, the team created a shielding material that is nearly 90 per cent lighter than traditional lead aprons, potentially reducing the back and neck injuries commonly experienced by health-care workers who wear them for extended periods.
UFC Vegas 118 Post-Fight Press Conference
Following tonight's UFC Vegas 118 fights last the Meta Apex in Las Vegas, the winners will answer questions during the post-fight press conference. The event was headlined by a welterweight bout between former champion Belal Muhammad and No. 11 ranked Gabriel Bonfim.
Allen’s Gamble Pays Off In Bloody Victory
Brendan Allen vs. Edmen Shahbazyan squared off in a Middleweight bout earlier tonight (Sat., June 6, 2026) at UFC Vegas 118 inside Meta Apex in Las Vegas, Nevada. In a fun and bloody fight, Allen extended his win streak to three. Allen came out aggressive, pressing forward and kicking at the lead leg. He didn’t […]
People are battling 'ghost fat' after losing weight on GLP-1s
Sometimes, seeing isn't believing.
The next goal for weight loss drugs? Fewer injections
Pfizer and Amgen are working on new GLP-1 shots designed to be taken once a month rather than weekly.
Ozempic and similar weight-loss drugs linked to 30% lower breast cancer risk
A large study found that women taking GLP-1 drugs, the medication class behind Ozempic, Wegovy, Mounjaro, and Zepbound, were about 30% less likely to develop breast cancer. Researchers say the findings are promising but not yet proof, and clinical trials are now being planned to test whether these drugs could help prevent breast cancer.
Tiny X-ray telescope could unlock the Moon's hidden chemistry
A lightweight new X-ray telescope could finally give scientists something they’ve never had before: a complete chemical map of the Moon. Researchers used detailed mission simulations to show that a compact telescope orbiting the Moon could identify key elements across the entire lunar surface, helping reveal how the Moon formed and evolved.
What Serena Williams' GLP-1 use means for longevity and performance
Serena Williams is part of a growing cohort of people using peptides like GLP-1 drugs for longevity, recovery, and performance — not just weight loss.
Mindy Kaling Reveals Weight Loss Journey and Health Motivations on the Red Carpet
She opened up about why she wanted to slim down.
Melinda French Gates is done waiting for health care to take menopause seriously
Celebrities like Halle Berry and Naomi Watts have jumped on menopause startups. Now Melinda French Gates is throwing her weight behind the category—with philanthropic dollars.
Scientists discover why ozempic may not work for some people
Scientists have identified genetic variants that may make some people less responsive to GLP-1 drugs used to treat Type 2 diabetes. Roughly 10% of the population carries these variants, which appear to cause a mysterious form of "GLP-1 resistance." In several clinical trials, carriers were significantly less likely to reach healthy blood sugar targets while taking GLP-1 medications.
BevNET Live: Everwell Health showcases science-backed functional beverage ingredients
Wellness ingredients supplier Everwell Health will be showcasing its “Ingredients for Life” portfolio of functional beverage solutions for caffeine-free energy, concentration, protein, and weight loss at the upcoming BevNET Live event next week in New York City, US (June 10–11). Everwell Health experts will be present at the show, highlighting how the company’s ingredients can help formulators create differentiated beverages that meet growing consumer demand for convenient, multifunctional, and health-focused beverages.
‘B—ch’ Move? Allen ‘Finessed’ By DDP Bait-And-Switch
This weekend (Sat., June 6, 2026) at UFC Vegas 118, No. 4-ranked Middleweight contender will take a significant step down the ladder to face unranked boxer Edmen Shahbazyan in the co-main event. Usually, there are extenuating circumstances when a Top 5-ranked contender fights outside the rankings. Some kind of losing streak is involved or the […]
The Supply Side: Grocery business responds to GLP-1 use
The rising use of GLP-1 weight-loss drugs is reshaping consumer spending, which impacts food retailers and suppliers. About 1 in 8 U.S. consumers use drugs that reduce appetites and curb...
Popular weight-loss diet shows surprising impact on serious mental health condition
New UC San Diego research suggests the keto diet may help reduce anorexia nervosa symptoms, with 72% of participants scoring in the recovered or normal range.
Decoding the Complex Science of Obesity
GLP-1. GIP. Amylin. Incretins. Peptides. NuSH. It’s not hard to see why the language surrounding modern obesity research sometimes feels like an alphabet soup of scientific terms. But behind each is a growing understanding of how the body regulates hunger, metabolism, energy use, and weight. It’s shaping what we know about how those systems might contribute to obesity.
Cole Hauser Says 106-Degree Texas Heat Made It Tough to Keep Weight on While Filming “Dutton Ranch” (Exclusive)
"I was trying to keep weight on," Hauser tells PEOPLE of filming the 'Yellowstone' spinoff in Texas
Why David Brooks Is (Mostly) Done With Politics
The controversial columnist wants to contemplate weightier issues.
Google's new Gemma 4 open AI model is sized for your laptop
Gemma 4 12B uses a new encoding scheme and token prediction to punch above its weight.
A new AI-powered computer worm could prove to be the stuff of cybersecurity nightmares
University of Toronto researchers built a worm powered by open-weight AI that adapts to its targets. Experts say it changes the math on cybersecurity defense
Popular GLP-1 weight-loss drugs linked to lower risks of addiction and overdose
A massive study of more than 600,000 U.S. veterans suggests that popular GLP-1 drugs such as semaglutide may do far more than help with diabetes and weight loss—they could also fight addiction itself. Researchers found that people taking these medications were less likely to develop substance use disorders involving alcohol, nicotine, cannabis, cocaine, opioids, and other drugs, while those already struggling with addiction experienced fewer overdoses, hospitalizations, emergency visits, and drug-related deaths.
Health insurer Cigna will stop covering GLP-1 weight loss drugs in its employee health plan
CNBC's Becky Quick reports on the latest news.
Telehealth Booms As Demand For GLP-1s Surges and Questions Mount About Safety, Oversight
By Lauren Sausser and Maia Rosenfeld and KFF Health News HealthDay ReportersWEDNESDAY, JUNE 3, 2026 (HealthDay News) — Within 24 hours of injecting the first dose of a weight loss medication she received following a visit with a telehealth doctor, Karleigh McClain was admitted to the hospital, she ...
The Science Behind the Quest for a Non-Peptide Oral Weight Loss Drug A
A combination of human and artificial intelligence has paved the way for a GLP-1 agonist that is effective when taken by mouth.
Could lifting weights actually help you live longer?
Regular weight training can significantly reduce the risk of early death, research suggests.
From The Sports Desk: Heavyweights Carolina, Vegas meet in Stanley Cup Final
We preview the matchup between the Hurricanes and the Golden Knights, before the series starts tonight. Plus, Germany’s Jamal Musiala is our World Cup spotlight of the day.
Rx Kids linked to reductions in preterm births and low birthweights, fewer NICU admissions
A pregnancy and postnatal cash prescription program in Flint Michigan has been linked to improved birth outcomes including reduced rates of low birthweight, preterm birth and NICU admission.
Why interviewing Anthony Joshua made me uncomfortable
COMMENT: Six months after the ex-heavyweight champion survived a car crash that killed two of his friends, he spoke to Alex Pattle and others about how he is coping – whether he wanted to or not
GLP-1 drugs like Ozempic show promise for more than weight loss. But what’s science vs hype?
Ozempic-style drugs have been flagged as possible treatments for cancer, dementia, endo, addiction and more. An expert explains what the evidence really says.
Towards a responsive health system and equitable access to quality RMNCAH services
Indonesia’s vast geography and sociocultural diversity shape the delivery of reproductive, maternal, newborn, child and adolescent health (RMNCAH) services in ways that are both enabling and challenging. Across provinces, significant variation has been observed in how services are planned, resourced, and delivered. These variations in service standards and quality are felt daily in the lives of women, newborns and adolescents. Despite these challenges, progress is visible. National estimates show a drop in maternal mortality ratio, from 331 to 140 per 100 000 live births since 2000, signaling improvements in care quality and access. Fertility has stabilised and contraceptive use has grown, yet unmet reproductive health needs persist, and adolescent pregnancies continue to reflect early marriage and limited access to youth-friendly services.To better understand how Indonesia’s health system has evolved under decentralisation, the Ministry of Health, supported by World Health Organization (WHO), United Nations Population Fund (UNFPA), the United Nations Children’s Fund (UNICEF), IPAS and the Asian Development Bank (ADB), conducted a joint external review of RMNCAH programmes. This review draws on multiple sources of evidence, including existing literature, policy documents, national health system data, as well as field visits to six selected provinces to represent Indonesia’s geographic and administrative diversity. During the field visits, review teams observed service delivery in health facilities, spoke with health workers and local leaders and met mothers and families to understand how RMNCAH policies are operationalised. One of the challenges identified was the management of low birthweight (LBW) infants, a major contributor to neonatal deaths, under resource constraints. One midwife described a severe case of extremely LBW twins, one stillborn and the other died after three days of care. She recalled how the surviving infant struggled to swallow and may not have received breast milk, while simultaneous emergencies required the team’s attention, affecting the care provided to the infant.A subsequent review of the case by the district health office revealed insufficient antenatal care, fragmented maternal medical history due to population mobility, referral delays, limited provider capacity in neonatal intravenous access and a heavy workload that constrained proper newborn monitoring. These insights informed recommendations to strengthen both system-wide and service-level responses. Since the early 2000s, Indonesia’s decentralisation initiative has given much of the responsibility for funding, staffing and managing health services to regional governments. While the Ministry of Health sets national clinical standards, daily management of public health facilities falls under regional authorities through the Ministry of Internal Affairs. While this arrangement allows services to be tailored to local needs, it also depends heavily on local capacity for planning, budgeting and management. Health facilities and district health offices are better positioned to translate national priorities into local action when they have access to consistent technical support, helping health workers manage resource constraints and infrastructure gaps.The complexity of Indonesia’s health system governance is no easy feat to navigate. Understanding these dynamics is essential to strengthening policy, improving coordination and ensuring more equitable access to services across Indonesia. Under the leadership of Ministry of Health, recommendations from this exercise will be key in guiding the nation’s roadmap to an equitable and quality health system for RMNCAH.Written by Edit Oktavia Manuama, National Professional Officer (Maternal, Newborn, and Child Health), and Jessie Yunus, National Professional Officer (Gender, Rights, Equity, and Disability Inclusion)
Planetary Health Diet May Lower Obesity Risk at Menopause
The planetary health and low-insulinemic diets — rich in plants and whole grains and low in red and processed meats and fried foods — can aid weight management during menopause, a recent study shows.
Toyota Turns Up the Thrill for 2027 with New Updates to GR86
PLEASANTON, Calif. (June 1, 2026) – Making its debut at FuelFest in the Bay Area, where car culture, performance, passion and the enthusiast community come together, the 2027 Toyota GR86 returns with a series of focused enhancements designed to deepen the connection between driver, car and road. Built for enthusiasts and engineered with input shaped by motorsports, the GR86 continues to deliver the kind of lightweight, rear-wheel-drive fun that has made it a favorite among sports car purists around the world.
Weight Loss Drugs Listed By Health Insurers Aren’t Necessarily Covered
Inclusion of weight loss drugs on insurer formularies is a meaningful step towards expanding access. But having a product listed doesn’t necessarily mean it’s covered.
‘The Cardinal Countdown: 97 Days Until Kickoff’
MAURICE DAVIS #97 Height: 6’4” Weight: 250lb Position: DL Class: Sophomore Hometown: Albany, GA Summary: The Cards grabbed Davis over a few SEC squads back in 2024 and are looking for his on field development to mirror that of his improved speed and quickness. Sitting behind some high caliber weapons on the depth chart when […]
Umar Nurmagomedov added to UFC Abu Dhabi in July
Umar Nurmagomedov will return as the co-main for UFC Abu Dhabi on July 25th, 2026. Overnight, the UFC made the big announcement: the No. 2 ranked bantamweight Nurmagomedov will face No. 9 ranked David Martinez at UFC Fight Night: Ankalaev vs. Rountree at Etihad Arena. This will be Nurmagomedov’s first fight since a dominant decision […]
Alexander Volkanovski gives Ilia Topura vs. Justin Gaethje prediction
A lightweight championship unification bout between champion Ilia Topuria and interim titleholder Justin Gaethje headlines the UFC Freedom 250 fight card on June 14 at the White House. It will be Topuria's first title defense. Topuria is a heavy betting favorite two weeks out from the event, but ...
Sergei Pavlovich calls for title shot after UFC Macau win
Third-ranked heavyweight contender Sergei Pavlovich went into his UFC Macau main card bout against up-and-comer Tallison Teixeira without a lot to gain. Teixeira was ranked No. 15 in the division. A win for Pavlovich wouldn't have moved the needle unless the win was quick and brutal. He delivered, ...
Harvard Lightweights Win Third Straight National Championship | Sports
Harvard Lightweights Win Third Straight National Championship | Sports | The Harvard Crimson
Move more for your health, not just for the scale
Statement Highlights: Regular physical activity improves blood pressure, insulin sensitivity, cholesterol levels and cardiorespiratory fitness in adults with overweight or obesity, independent of weight loss, according to a new scientific statement...
Lightweight clash added to UFC Belgrade lineup
Ludovit Klein will lock horns with Tofiq Musayev at UFC Belgrade.
Azim signals world-title intent with stoppage win
British light-welterweight Adam Azim continues his march towards a world-title shot with a third-round stoppage win over Steve Claggett in London.
Trump's Doctor Says He's in 'Excellent Health,' Urges Weight Loss
The White House released a report from President Trump’s latest medical visit. Here’s what it says.
Trump’s doctor recommends he lose weight, exercise more but says he is in ‘excellent health’
The White House released the results of President Donald Trump’s May physical late Friday evening, with his physician recommending he lose weight and exercise more while noting he is in "excellent health."
White House releases Trump's physical results, says he's in 'excellent health' but almost obese
The White House doctor recommended increased physical activity and weight loss.
UFC Macau Results: Song vs. Figueiredo
Song Yadong, Deiveson Figueiredo battle to stay in the bantamweight contender picture
White House Releases Results of Trump’s Latest Physical Exam
The report by President Trump’s physician said he was in “excellent health.” It showed that he had gained weight and that neurological and heart tests had come back “normal.”
Trump’s doctor recommends he lose weight and exercise more but says he is in "excellent health’
The White House released the results of President Donald Trump’s May physical late Friday evening, sharing a memo from his physician recommending he lose weight and exercise more while noting he is in excellent health.
Trump’s doctor recommends he lose weight and exercise more but says he is in "excellent health’
The White House released the results of President Donald Trump’s May physical late Friday evening, sharing a memo from his physician recommending he lose weight and exercise more while noting he is in excellent health.
UFC Macau Start Time, Full Fight Card Details!
Ultimate Fighting Championship (UFC) is back in Macau SAR, China TODAY (Sat., May 30, 2026) to stage UFC Macua from inside Galaxy Arena featuring a banger of a Bantamweight bout between Yadong Song and Deiveson Figueiredo, while Alonzo Menifield and Zhang Mingyang battle in a Light Heavyweight bout in the co-main event on Paramount+. What’s […]
Conor McGregor Rolls Out Extra KO Bonuses For BKFC 90
Conor McGregor is raising the stakes for this weekend’s BKFC 90 fight card from Birmingham, England, as the former UFC double champion rolled out new knockout bonuses for every single bout. This weekend will feature a headlining title fight between BKFC U.K. welterweight champion Connor Tierney and veteran knockout artist Rico Franco. However, the main […]
Champions League Finalists Arsenal, PSG Worth Combined $10B+
Global soccer heavyweights Arsenal and Paris Saint-Germain face off Saturday in the Champions League final in Budapest, Hungary. They are both chasing history, with Arsenal looking for its first top-tier European crown, and PSG eyeing back-to-back titles, something only Real Madrid has accomplished since the tournament was rebranded as Champions League in 1992. The game …
An experimental GLP-1 pushes the limits of weight loss. There are risks.
Eli Lilly is developing the the most powerful GLP-1 drug yet. But how much weight loss is too much?
UFC Macau: Song vs. Figueiredo weigh-in results
The UFC Macau: Song vs. Figueiredo weigh-ins are in the books. All fighters hit their marks on Friday in China. The event is headlined by a bantamweight bout between No. 5 ranked Song Yadong and No. 7 ranked former flyweight champion Deiveson Figueiredo. Figueiredo tipped the scales slightly ...
Weight-loss drugs like GLP-1s are easy to buy online raising overdose and safety concerns
Many telehealth companies have emerged in recent years offering easy access to GLP-1 weight loss drugs as demand has exploded.
France to reimburse weight-loss drugs from mid-June, health minister says
France will reimburse the cost of weight-loss drugs for severely obese patients from mid-June, Health Minister Stephanie Rist said on Thursday in an interview with TF1 channel.
Holly Holm wasn't surprised by Ronda Rousey returning
Ronda Rousey's dominating three-year reign atop the UFC women's bantamweight division was brought to a sudden halt by Holly Holm at UFC 193 in November 2015. Holm knocked out Rousey with a head kick early in the second round sending shockwaves throughout the combat sports world. Rousey returned to ...
Do anti-obesity medications affect bone health?
Learn about a new study to examine if GLP-1 weight loss medications have an effect on bone density.
Expected NC budget won’t restore GLP-1 weight-loss drug coverage for state employees, treasurer says
State Treasurer Brad Briner doesn’t expect North Carolina lawmakers to include funding in the upcoming budget to restore State Health Plan coverage of GLP-1 drugs for weight loss, as costs and competing budget priorities keep the benefit off the table.
AI-native software helps a luxury blanket brand avoid costly returns
Luxome partners with LiquiDonate to donate returned weighted blankets to nonprofits, reducing landfill waste with AI-driven solutions.
Study links eight heart-healthy habits to lower diabetes risk in postmenopausal women
Type 2 diabetes is often associated with excessive sugar intake, but lifestyle factors including body weight, exercise, and smoking habits can also influence risk. A new study published in Diabetology ...
Signos grows foothold in weight-loss wave fueled by GLP-1s with its AI health data tracking
Health tech startup Signos announced a $20 million funding round Wednesday, including an expanded partnership with medical device giant Dexcom.
Mindy Kaling Says Her Weight Loss Was Motivated by Wanting to Be Healthy and ‘Look Hot’: 'Both Can Be True'
During a recent appearance on 'The View,' Mindy Kaling addressed public reactions to her weight loss, saying it’s been a personal goal since childhood.
The Lotus Emira 420 Sport Adds Power And Cuts Weight
It also gains a removable glass roof panel.
Swedish prospect forced to pause UFC career due to ‘serious health problems’
Get well soon, “Bane.” Rising Ultimate Fighting Championship (UFC) Welterweight prospect Andreas Gustafsson has reportedly been forced to step away from competition because of serious health complications, leading to his scheduled fight against Daniil Donchenko at UFC Baku next month (Sat., June 27, 2026) being scrapped. According to Swedish outlet Frontkick.com, Gustafsson is currently dealing […]
Conor McGregor’s Manager Drops Hint About Future Michael Chandler Fight
Conor McGregor's manager teased fans about the possibility of a future fight against top lightweight contender Michael Chandler.
Scientists discover why Ozempic and Wegovy weight loss eventually plateaus
New NIH research reveals that semaglutide sparks different responses inside appetite-controlling brain cells, offering fresh insight into why GLP-1 weight-loss drugs don’t work the same for everyone. Scientists also found a possible way to extend the drugs’ effects, potentially helping patients push past weight-loss plateaus.
Use Tiny11 to Rescue a Computer Running Windows 10
If you can’t—or don’t want to—upgrade to full Windows 11, consider this lightweight version of Microsoft’s operating system that works on a wide range of computers.
Steelers' Broderick Jones Has Alarming 'Weight' Worry
A lingering neck injury and significant offseason weight loss leave the former first-round pick’s status in doubt as he fights for his future during a pivotal contract year.
Oleksandr Usyk: Frank Warren 'will not stand' for Rico Verhoeven rematch over Agit Kabayel heavyweight title clash
Hims & Hers CEO is plotting new ways to upend traditional health care
Hims & Hers built massive weight-loss markets using telehealth. Peptides, if authorized by the FDA, stand to become a major part of the company’s shift to wellness and longevity.
What next for heavyweight division after Usyk's win?
After Oleksandr Usyk beats Rico Verhoeven to retain his heavyweight world titles, who could he fight next?
Oleksandr Usyk beats Rico Verhoeven: What next for heavyweight division?
After Oleksandr Usyk beats Rico Verhoeven to retain his heavyweight world titles, who could he fight next?
AI scans 400,000 Reddit posts and finds hidden Ozempic side effects
By analyzing over 400,000 Reddit posts, researchers discovered that users of popular GLP-1 weight-loss drugs frequently discussed unexpected symptoms like menstrual irregularities, chills, and hot flashes. The findings suggest AI could turn social media into a powerful early-warning system for spotting side effects that clinical trials may miss.
Highlights! Usyk Survives Rico, Bad Stoppage Tarnishes Win
Pound-for-pound great, Oleksandr Usyk, was back in action earlier today (Sat., May 23, 2026), defending his WBC Heavyweight title against kickboxing legend, Rico Verhoeven, in front of the Pyramids of Giza in Cairo, Egypt, in what was truly a one-of-kind setting for a boxing match. It took a bit for Usyk to get warmed up, […]
Wegovy linked to rare “eye stroke” that can cause sudden blindness
A new analysis is raising concerns about Wegovy, the blockbuster weight-loss drug, after researchers found it may carry the highest risk of a rare “eye stroke” that can cause sudden vision loss. The study, based on millions of FDA side-effect reports, found the risk signal was nearly five times stronger for Wegovy than for Ozempic, despite both containing semaglutide.
Oh, Hello: Utah DT Aniti Paiva Commits To Penn State
THE SKINNY Height/Weight: 6-foot-3, 300 poundsHometown/High School: Draper, Utah (Skyline H.S.)Ranking: ★★★ (87 Rivals — No. 94 DT)Notable Offers: Arizona, Boise State, Colorado, Oregon State, Washington State HIGHLIGHTS OUTLOOK Kalani Sitake might have turned down the Penn State job, but the Nittany Lions are still in the Utah business thanks to defensive tackles coach Ikaika […]
Paxton makes his final pitch in the Texas Senate race against Cornyn, buoyed by Trump's endorsement
Republican Ken Paxton is riding high as the Texas attorney general heads into the final days of the U.S. Senate primary runoff against incumbent John Cornyn, now with the weight of President Donald Trump's backing.
How body weight exercises can improve your health
Valorant's new Vanguard update seems to be bricking cheaters' PCs. Riot's response? "Congrats on your $6k paperweights"
Riot's latest Vanguard update is bricking cheaters' PCs, to the point where they have to do full OS reinstalls, and it's not sorry. At all.
How Amari Jones became one of Golden Boy’s hottest prospects
Jones has a solid support system that includes pound-for-pounder Devin Haney, and he's firmly focused on making waves in the middleweight division.
Weight loss medications heavy on Fort Worth’s employee health plan
Skyrocketing use of weight loss medications such as Ozempic, Wegovy and Zepbound drives up insurance claims for the city of Fort Worth.
Popular weight loss drugs like Wegovy may also target arthritis inflammation
Researchers have discovered that the GLP-1 hormone targeted by drugs like Wegovy is present in very low amounts inside the joints of arthritis patients. That finding suggests high-dose GLP-1 medications could potentially reach the joints and influence inflammation directly, not just help through weight loss. Scientists say this could open the door to a completely new approach to arthritis treatment.
Popular Weight Loss Drugs May Have Surprising Side Effect: Stalling Cancer
A suite of new studies suggest drugs such as Ozempic and Zepbound might slow tumor progression and improve survival, but more research is needed to confirm the findings.
The Science Behind the Quest for a Non-Peptide Oral Weight Loss Drug
Not only does it have a tongue-twisting name, “orforglipron” has a complex molecular structure that made its synthesis very challenging. A massive effort by chemists at the Eli Lilly pharmaceutical
New obesity treatment may help preserve muscle during weight loss
Gwyneth Paltrow and neuroscientist Andrew Huberman explore retatrutide, a new triple-agonist GLP-1 therapy said to reduce side effects and spare muscle.
Inside Mindy Kaling's Weight Loss Journey and Her New Motivation for Staying Healthy
Mindy Kaling has been open about her physical transformation and weight loss journey over the years. Here's everything she has said about her health.
From Germany: Josko Gvardiol targets summer Manchester City exit
Croatian international defender Josko Gvardiol is reportedly considering a departure from the Etihad Stadium after just three seasons in England.Bundesliga heavyweights Bayern Munich are monitoring th...
Dartmouth Health study could point way to sustained weight loss for those who stop using GLP-1 drugs
GLP-1 drugs have transformed obesity treatment, but many patients regain weight after stopping the medication. A new study could point the way to a solution.
Bradenton icon Gene Gallo throws weight behind Melton Little in HD 71 race
'I'm honored to have Gene Gallo's support.'
Withings Body Scan smart scale review: Premium health insights, premium price
The Withings Body Scan is not your everyday smart scale. Sure, it tracks your weight and body composition, but it also measures ECG, assesses the flexibility of your arteries and detects nerve activity in your feet.
People who lost the most weight on Ozempic saw huge health benefits
People who lost significant weight while taking Ozempic, Wegovy, Mounjaro, or Saxenda had sharply lower risks of major obesity-related health problems, including sleep apnea and kidney disease. Those who gained weight instead faced higher risks — especially for heart failure — even though many patients discontinued the medications within a year.
What Is ‘Ozempic Personality’? Patients Say GLP-1 Left Them Emotionally Flat
Some patients taking GLP-1 weight-loss drugs report less pleasure and excitement in life. “It is not in their heads,” doctor says. How to get help if you’re feeling less joy on the medication.